Scientist Solutions: International Life Science Community By Scientists For Scientists
    
Home » Protocols » Preclinical Models of Hepatic Encephalopathy
Thanks to our sponsors who make this site possible
Protocol for

Preclinical Models of Hepatic Encephalopathy

Would you like to save this topic, event, protocol or job so you can find it again easily?

Just click the "Save to My Lab Drawer" link and the item will be saved in the My Lab Drawer section of your bench space.

Available to members only. Please log in or register for your free account now.

Abstract or Description:

Parkinson's disease is a neurodegenerative disease in which pigmented midbrain neurons progressively die producing a dopamine (DA) deficit in the striatum which manifests as an akinetic movement disorder. Experimentally induced striatal DA depletion in animals is a valid model of parkinsonism. The capacity of certain substances to damage catecholaminergic neurones has been used for a long time to produce DA deficiency in animals. This unit focuses on methods for inducing parkinsonism using the neurotoxins MPTP and 6-hydroxy dopamine and methods for evaluating the animals. Other models are briefly reviewed.

Citation: DOI: 10.1002/0471142301.ns0904s09
Attachments: No Attachments
Posted By: ProtocolFinder on 7/6/2009 7:15:08 PM
Comments
Add Comment